Protheragen Debuts Microbiota Research Service for Obesity

Nov 20, 2026

United States, November 20, 2026 /MarketersMEDIA/ -- Protheragen, a specialized Contract Research Organization (CRO) dedicated to preclinical obesity research, today announced the launch of its Obesity Microbiota Research Service, an end-to-end research solution designed to examine the relationship between gut microbiota and obesity. The service encompasses animal model development, sample collection, 16S rRNA gene sequencing and/or shotgun metagenomic sequencing, and advanced bioinformatics and analytics. Leveraging research in obesity, microbiomics, and systems biology, the service focuses on identifying and prioritizing microbial targets that can aid in the development of next-generation anti-obesity therapeutics for biotechnology and pharmaceutical companies.

Research indicates that imbalances in gut microbial populations can influence the development of metabolic disorders and obesity, and ongoing work aims to elucidate the mechanisms by which these microbial populations contribute to obesity and to develop therapeutic strategies that modulate them. Protheragen's Obesity Research Platform provides biotechnology and pharmaceutical companies with an integrated system to perform preclinical research on obesity and related disorders, facilitate the identification of therapeutic targets, and support the development of personalized microbiome-modulating strategies.

The Obesity Microbiota Research Service standardizes and streamlines its processes to provide clients with reproducible data. Once an appropriate animal model (e.g., mice or rats) is selected, the service can induce obesity using various means, including dietary manipulations, environmental modifications, and genetic manipulations. After sample collection (e.g., blood, feces, and intestinal tissues), the service provides specialized processing to protect the microbial contents and increase the precision of analysis. The service uses various techniques—including 16S rRNA gene sequencing, metagenomics, and metabolomics—to characterize microbial components and their metabolites, and to elucidate their effects on host physiology. Various bioinformatics and statistical tools are used to analyze the data and draw conclusions regarding the functional capabilities of the microbial components and their roles in obesity. This service provides clients with the ability to understand functionally important microbial components and groups, identify dysbiotic microbiota associated with obesity, and support the development of microbiota-based therapies for obesity.

Beyond microbiota-focused studies, the Obesity Microbiota Research Service is part of the broader Obesity Research Platform, which supports the entire spectrum of anti-obesity therapeutic development—including small-molecule drugs that modulate the gut microbiota, gene and cell therapies, antibody therapies, tissue engineering, and other transformative approaches. Rigorous preclinical validation is conducted to provide scientific justification for advancing a therapeutic candidate to clinical trials. Each candidate undergoes pharmacodynamic and pharmacokinetic studies, toxicological evaluation, and safety assessment, with bioanalytical support provided throughout.

About Protheragen

Protheragen is a specialized Contract Research Organization (CRO) dedicated to advancing preclinical research in obesity. Driven by a passion for scientific innovation and a commitment to client success, the company has established a reputation for delivering high-quality data, actionable insights, and tailored solutions that drive breakthroughs in obesity therapeutics. Its integrated Obesity Research Platform seamlessly combines expertise across metabolism, inflammation, and cardiovascular biology, enabling a holistic approach to obesity research and therapy development. The company maintains quality control standards throughout its preclinical services to support the integrity and regulatory acceptance of generated data. For more information about the Obesity Microbiota Research Service, please contact Protheragen.

Contact Info:
Name: Anna White
Email: Send Email
Organization: Protheragen
Website: https://www.obesityscientific.com/

Release ID: 89210336

If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release, or if there is a need for a press release takedown, we urge you to notify us without delay at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond within 8 hours – ensuring swift resolution of identified issues or offering guidance on removal procedures. Delivering accurate and reliable information is fundamental to our mission.

More News

‘Absolute perfection!’ Gillingham youngster's incredible strike leaves dad beaming
Nov 17, 2026
‘Absolute perfection!’ Gillingham youngster's incredible strike leaves dad beaming

Gillingham teenager Cruz Beszant showed what he's got in his locker after scoring a stunning 50-yard goal at the weekend.

Players are hurting too, insists Gillingham’s stand-in captain after defeat
Nov 17, 2026
Players are hurting too, insists Gillingham’s stand-in captain after defeat

Gillingham defender Omar Beckles insists the players are hurting as much as the fans after Saturday’s defeat at Colchester United.

Multi-talented sportsman dies, aged 90
Nov 16, 2026
Multi-talented sportsman dies, aged 90

Former County Championship-winning Kent and England bowler Alan Brown, who also enjoyed a prolific non-league football career, has died.

FA Trophy third round draw
Nov 16, 2026
FA Trophy third round draw

The draw has been made for the third round of the FA Trophy.

Ex-captain to become county’s new director of cricket
Nov 16, 2026
Ex-captain to become county’s new director of cricket

A former Kent captain is to become the county’s new director of cricket.

KentOnline’s team of the week
Nov 16, 2026
KentOnline’s team of the week

Find out who’s in KentOnline’s team of the week and vote for your star man.

Fans wanted him to stay on - but Ainsworth explains why he had to act
Nov 16, 2026
Fans wanted him to stay on - but Ainsworth explains why he had to act

Gillingham boss Gareth Ainsworth has explained why he had to take Zane Albarus off on Saturday.

Ainsworth identifies Gillingham weakness after Colchester defeat
Nov 14, 2026
Ainsworth identifies Gillingham weakness after Colchester defeat

Set-piece training will be high on the agenda next week after Gillingham threw away any chance of a win on Saturday.

What a day as nine league games produce 47 goals
Nov 14, 2026
What a day as nine league games produce 47 goals

Kennington scored eight while Snodland bagged seven as nine games in the Southern Counties East Premier Division produced 47 goals.

Striker scores four as leaders secure 10th successive home win
Nov 14, 2026
Striker scores four as leaders secure 10th successive home win

Kaan Bennett scored all four goals as Isthmian Premier leaders Welling United made it a perfect 10 at home.

Report: Gillingham undone by quickfire second-half double
Nov 14, 2026
Report: Gillingham undone by quickfire second-half double

Gillingham became the first side since late August to lose to Colchester United in the league on Saturday.

Matchday Live: Colchester v Gillingham, Dartford v AFC Totton, Maidstone v Maidenhead
Nov 14, 2026
Matchday Live: Colchester v Gillingham, Dartford v AFC Totton, Maidstone v Maidenhead

Follow this afternoon’s football in our live blog, including Gillingham’s trip to Colchester in League 2.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Daily Sports Global

Daily Sports Global, your guide to the best sports news on the Internet. Access to the world’s biggest sports events right here even if you’re not physically there.

Newsletter